First Trust Advisors LP Acquires 1,305 Shares of Eli Lilly and Company $LLYMarket Beat·2 days ago, 02:52 AMLLY+0.86%ELIL+1.89%
Cardiovascular disease biotech Scribe Therapeutics prices upsized IPO at $15, the high end of the rangeRenaissanceCapital·2 days ago, 07:21 AMSNY-2.00%LLY+0.86%
Genmab, AbbVie clarify primary endpoints in Phase 3 EPCORE DLBCL-1 trialPUBT·Jul 23 at 03:00 PMGMAB-1.03%ABBV+0.95%
23:20 ETPRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Recordsprnewswire·2 days ago, 10:21 PMABT+2.29%EXAS0.00%
Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trialsrttnews·Jul 23 at 06:15 AMLLY+0.86%ELIS0.00%
J&J Says TECVAYLI+TALVEY Cuts Risk Of Disease Progression Or Death By 89% In Multiple Myeloma Trialrttnews·Jul 23 at 08:09 AMJNJ+1.59%
Johnson & Johnson posts press release on MonumenTAL-6 multiple myeloma trial resultsPUBT·Jul 23 at 07:30 AMJNJ+1.59%
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trialsCNBC·Jul 23 at 05:45 AMLLY+0.86%ELIS0.00%
Amgen submits data to FDA, challenges proposed Tavneos market withdrawalPUBT·2 days ago, 07:24 AMAMGN+1.22%
HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%PUBT·2 days ago, 11:40 PMLLY+0.86%ELIS0.00%
Johnson & Johnson's Ottava gets FDA approval; Goldman launches private-company investing platformCoinLive·Jul 22 at 02:05 PMJNJ+1.59%GS-D+0.31%
Bank of Nova Scotia Cuts Stock Position in AbbVie Inc. $ABBVMarket Beat·2 days ago, 02:30 AMABBV+0.95%
Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in USPUBT·Jul 22 at 06:04 AMJNJ+1.59%
